Edmonds, WA, United States of America

A Charles Morgan, Jr


Average Co-Inventor Count = 2.1

ph-index = 10

Forward Citations = 612(Granted Patents)


Location History:

  • Camino Island, WA (US) (1998)
  • Mill Creek, WA (US) (1998 - 2000)
  • Edmonds, WA (US) (1991 - 2008)

Company Filing History:


Years Active: 1991-2008

Loading Chart...
15 patents (USPTO):Explore Patents

Title: A Charles Morgan, Jr.: Innovator in Vitamin B Receptor Modulation

Introduction

A Charles Morgan, Jr. is an accomplished inventor based in Edmonds, WA, recognized for his contributions to the field of biochemistry and pharmaceutical sciences. With a remarkable portfolio of 15 patents, Morgan has significantly advanced the understanding of vitamin B receptors and their modulation, paving the way for innovative therapeutic strategies.

Latest Patents

Among his latest patents, Morgan's work on "Growth Blocking Agents" stands out. This invention discloses anti-receptor and growth blocking agents targeting the vitamin B/transcobalamin II receptor. These agents are designed to antagonize or modulate the receptor, leading to cellular depletion of vitamin B, inhibiting cell division, and promoting apoptosis. The patent encompasses various forms of these agents, including proteins, peptides, and small organic molecules, with a preferred embodiment involving an antibody specifically targeting the vitamin B/transcobalamin II receptor.

Another notable patent is focused on "Water Soluble Vitamin B12 Receptor Modulating Agents and Methods." This invention introduces agents capable of modulating cell surface receptors by influencing the trafficking pathways of these receptors. These modulating agents consist of a covalently bound rerouting moiety paired with a targeting moiety, interconnected by a water-solubilizing linker. This innovation potentially opens new doors in therapeutic approaches for diseases related to vitamin B deficiencies.

Career Highlights

Throughout his career, A Charles Morgan, Jr. has been associated with prominent companies such as Neorx Corporation and Receptagen Corporation. His work has consistently centered on enhancing drug efficacy through innovative receptor modulation techniques.

Collaborations

Collaboration has played an essential role in Morgan's career. He has worked alongside esteemed colleagues, including D Scott Wilbur and David C Anderson, contributing to the collective knowledge and advancements in the field of pharmacy and biochemistry.

Conclusion

A Charles Morgan, Jr. exemplifies the spirit of innovation in modern science. His extensive patent portfolio and collaborative efforts signify his impact in receptor biology and therapeutic advancements. As the field continues to evolve, Morgan's inventions and contributions will remain influential in the ongoing quest for novel treatments targeting vitamin B receptor pathways.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…